As we've mentioned before, the 2019 Medical Innovation Summit boasts our biggest agenda yet. We have 10 plenary sessions and 9 keynotes & fireside chats across all three days, 7 Featured Tracks across Monday and Tuesday, 16 concurrent Impact Sessions on Tuesday afternoon, 3 networking receptions and 5 different partner events over the course of the week.
Take a look below for a sneak peak of two of our plenary sessions!
Precision Health & the AI Perspective
If the healthcare ecosystem intends to transition from symptom-based and reactive, to personalized, predictive, and preventive, then AI paired with multi-disciplinary expertise is the technology best-positioned to respond to the clarion call. Join us as we explore the ground-breaking tools we have at our disposal to achieve these goals for healthcare. Here panelists will discuss the people, processes, and infrastructure needed to be ready for this new intelligent frontier.
Moderator: Will Morris, MD, Executive Medical Director, Cleveland Clinic Innovations
Michael Howell, MD, PhD, Chief Clinical Strategist, Google Health
David Karow, MD, PhD, President & Chief of Radiogenomics, Human Longevity Inc.
Steve Kearney, Chief Medical Officer, SAS
AI and the Disruption of Drug Development
Recent industry partnerships show increased integration of AI in the field of drug development. AI holds the promise to enhance the pharma process through its ability to rapidly screen compounds and streamline the steps from agent discovery to marketable drug - without sacrificing safety and efficacy. But how much of this promise is being realized today and when will its true impact hit?
Moderator: Casey Cunningham, MD, Chief Scientific Officer, Sante Ventures
Aashima Gupta, Global Head, Healthcare Solutions, Google Cloud
David Kappos, Partner, Cravath, Swaine & Moore
Rod MacKenzie, PhD, Executive Vice President, Chief Development Officer, Pfizer
The Summit is two weeks away - don't miss out on this incredible agenda! Register today!